Cellen Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Cellen General Information

Description

Operator of a digital healthcare clinic intended to improve the well-being of people living with chronic pain. The company utilizes technology to offer personalized integrated digital pain management services, improves data on alternatives to opioid medicines, offers cannabinoid medications as well as guides doctors on how to write medical cannabis prescriptions, enabling clients to improve research and discover therapeutics to improve the quality of life for patients with persistent pain.

Contact Information

Formerly Known As
Cellen Biotech
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Cannon Place
  • 78 Camron Street
  • London EC4N 6AF
  • England, United Kingdom
+44 020
Primary Industry
Other Healthcare Services
Other Industries
Clinics/Outpatient Services
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Corporate Office
  • Cannon Place
  • 78 Camron Street
  • London EC4N 6AF
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Admin/Reorg 01-Sep-2024 Completed Bankruptcy: Admin/Reorg
3. Merger/Acquisition 29-Jun-2022 Completed Generating Revenue
2. Corporate 28-Jan-2020 $1.31M $1.31M Completed Generating Revenue
1. Early Stage VC 21-Aug-2019 Completed Generating Revenue
To view Cellen’s complete valuation and funding history, request access »

Cellen Patents

Cellen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026154391-A Method and apparatus for producing solid fuel for microbial power generation equipment Pending 18-Mar-2025
JP-2025170498-A Microbial fuel cell and method for manufacturing the same Pending 07-May-2024
JP-7573922-B1 Solid microbial fuel cell and method for producing same Active 07-May-2024
JP-2025170497-A Solid microbial fuel cell and method for producing the same Active 07-May-2024
WO-2025234343-A1 Solid-state microbial fuel cell and production method therefor Pending 07-May-2024
To view Cellen’s complete patent history, request access »

Cellen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellen Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Óskare Capital Venture Capital Minority
To view Cellen’s complete investors history, request access »

Cellen FAQs

  • When was Cellen founded?

    Cellen was founded in 2019.

  • Where is Cellen headquartered?

    Cellen is headquartered in London, United Kingdom.

  • What is the size of Cellen?

    Cellen has 3 total employees.

  • What industry is Cellen in?

    Cellen’s primary industry is Other Healthcare Services.

  • Is Cellen a private or public company?

    Cellen is a Private company.

  • What is Cellen’s current revenue?

    The current revenue for Cellen is .

  • How much funding has Cellen raised over time?

    Cellen has raised $1.31M.

  • Who are Cellen’s investors?

    Óskare Capital has invested in Cellen.

  • When was Cellen acquired?

    Cellen was acquired on 01-Sep-2024.

  • Who acquired Cellen?

    Cellen was acquired by Akanda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process